Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (331) 331
Publication (57) 57
Book Review (39) 39
Conference Proceeding (16) 16
Patent (16) 16
Book Chapter (7) 7
Book / eBook (3) 3
Web Resource (3) 3
Newspaper Article (2) 2
Dissertation (1) 1
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (225) 225
humans (218) 218
oncology (177) 177
female (82) 82
cancer (73) 73
male (56) 56
neoplasms - drug therapy (50) 50
middle aged (49) 49
adult (48) 48
tumor cells, cultured (45) 45
antineoplastic agents - therapeutic use (36) 36
antineoplastic agents - pharmacology (34) 34
treatment outcome (32) 32
aged (31) 31
drug resistance (31) 31
abridged index medicus (30) 30
article (30) 30
drug resistance, neoplasm (30) 30
chemotherapy (27) 27
expression (27) 27
research (27) 27
animals (26) 26
apoptosis (23) 23
microtubules - drug effects (23) 23
tumors (23) 23
multidrug-resistance (22) 22
paclitaxel - pharmacology (22) 22
cell line, tumor (19) 19
p53 (19) 19
survival (19) 19
adolescent (18) 18
mutation (18) 18
p-glycoprotein (18) 18
tubulin - metabolism (18) 18
biochemistry & molecular biology (17) 17
paclitaxel (17) 17
therapy (17) 17
care and treatment (16) 16
cell biology (16) 16
drug therapy (16) 16
human necessities (16) 16
hygiene (16) 16
medical or veterinary science (16) 16
microtubules (16) 16
neoplasms - metabolism (16) 16
preparations for medical, dental, or toilet purposes (16) 16
tumor suppressor protein p53 - metabolism (16) 16
young adult (16) 16
disease-free survival (15) 15
gene (15) 15
mice (15) 15
analysis (14) 14
breast-cancer (14) 14
drug resistance, neoplasm - genetics (14) 14
hematology, oncology and palliative medicine (14) 14
pharmacology & pharmacy (14) 14
phase-ii trial (14) 14
tubulin (14) 14
united states (14) 14
antibiotics, antineoplastic - pharmacology (13) 13
antineoplastic combined chemotherapy protocols - therapeutic use (13) 13
carcinoma (13) 13
cell lung-cancer (13) 13
doxorubicin - pharmacology (13) 13
endocrinology & metabolism (13) 13
genetic aspects (13) 13
kidney neoplasms - drug therapy (13) 13
metastasis (13) 13
neoplasm metastasis (13) 13
neoplasms - genetics (13) 13
paraganglioma (13) 13
pheochromocytoma (13) 13
polymerase chain reaction (13) 13
aged, 80 and over (12) 12
antineoplastic agents, phytogenic - pharmacology (12) 12
atp-binding cassette, sub-family b, member 1 - antagonists & inhibitors (12) 12
binding (12) 12
carcinoma, renal cell - drug therapy (12) 12
dose-response relationship, drug (12) 12
health aspects (12) 12
histone deacetylase inhibitors (12) 12
neoplasms - pathology (12) 12
retrospective studies (12) 12
taxol (12) 12
tumor cells, cultured - drug effects (12) 12
adrenal-cortical carcinoma (11) 11
atp-binding cassette, sub-family b, member 1 - metabolism (11) 11
cells (11) 11
clinical trials (11) 11
clinical trials as topic (11) 11
dna damage (11) 11
gene mutations (11) 11
hematology (11) 11
lines (11) 11
management (11) 11
mutations (11) 11
proteins (11) 11
renal-cell carcinoma (11) 11
solid tumors (11) 11
tumor suppressor protein p53 - genetics (11) 11
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. The role of microtubules in cell biology, neurobiology, and oncology
by Fojo, Antonio Tito, 1952
2008, Cancer drug discovery and development, ISBN 9781588292940, xviii, 587
The family of proteins called the tubulin and the microtubules they form when they aggregate are extremely important in the cell and, as we are increasingly... 
Chemotherapy | drug therapy | Microtubules | Neurobiology | Cytology | Neoplasms | Cancer | Clinical & internal medicine | Oncology | Medicinal Chemistry | Cancer Research | Biomedicine | Pharmacology/Toxicology
Book
Details down arrow
2. Full Text How Much Is Life Worth: Cetuximab, Non-Small Cell Lung Cancer, and the $440 Billion Question
by Fojo, Tito and Grady, Christine
Journal of the National Cancer Institute, ISSN 0027-8874, 8/2009, Volume 101, Issue 15, pp. 1044 - 1048
The spiraling cost of cancer care, in particular the cost of cancer therapeutics that achieve only marginal benefits, is under increasing scrutiny. Although... 
PHASE-III TRIAL | ADJUVANT CHEMOTHERAPY | PLUS GEMCITABINE | GROWTH-FACTOR RECEPTOR | 1ST-LINE TREATMENT | THERAPY | ONCOLOGY | BEVACIZUMAB | CARCINOMA | METASTATIC COLORECTAL-CANCER | HER2-POSITIVE BREAST-CANCER | Drug Costs | Lung Neoplasms - drug therapy | Public Opinion | United States | Humans | Receptor, Epidermal Growth Factor - drug effects | Antibodies, Monoclonal - therapeutic use | Antineoplastic Agents - therapeutic use | Drug Approval | Antibodies, Monoclonal, Humanized | Clinical Trials, Phase III as Topic | Drug Industry - economics | Antineoplastic Combined Chemotherapy Protocols - economics | Cetuximab | United States Food and Drug Administration | Quality-Adjusted Life Years | Neoplasms - economics | Treatment Outcome | Antineoplastic Agents - economics | Neoplasms - drug therapy | Carcinoma, Non-Small-Cell Lung - economics | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Cost-Benefit Analysis | Survival Analysis | Value of Life | Lung Neoplasms - economics | Carcinoma, Non-Small-Cell Lung - drug therapy | Antibodies, Monoclonal - economics | Economic aspects | Lung cancer, Non-small cell | Drug therapy | Clinical trials | Oncology | Chemotherapy | Lung cancer | Cost control | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Desperation Oncology
by Fojo, Tito
Seminars in Oncology, ISSN 0093-7754, 06/2018, Volume 45, Issue 3, pp. 105 - 106
ONCOLOGY | Neoplasms - metabolism | Medical Oncology - methods | Immunotherapy - methods | Neoplasms - therapy | Neoplasms - immunology | Humans | Medical Oncology - trends | Immunotherapy - adverse effects
Journal Article
Details down arrow
4. Cancer therapies and the problem of me too many
by Fojo, Tito
Seminars in Oncology, ISSN 0093-7754, 04/2017, Volume 44, Issue 2, pp. 113 - 113
ONCOLOGY | Antineoplastic Agents, Immunological - therapeutic use | Humans | Antineoplastic Agents - pharmacology | Antineoplastic Agents - therapeutic use | Drug Discovery | Antineoplastic Agents, Immunological - pharmacology | Neoplasms - drug therapy
Journal Article
Details down arrow
5. The role of microtubules in cell biology, neurobiology, and oncology
by Fojo, Antonio Tito, 1952
2008, Cancer drug discovery and development, ISBN 9781588292940
Chemotherapy | drug therapy | Microtubules | Neurobiology | Cytology | Neoplasms | Cancer
Web Resource
Details down arrow
6. The role of microtubules in cell biology, neurobiology, and oncology
by Fojo, Antonio Tito, 1952
2008, Cancer drug discovery and development, ISBN 1597453366
Chemotherapy | drug therapy | Microtubules | methods | Cytological Techniques | Neurobiology | Cytology | physiology | Neoplasms | Nervous System Diseases | Cancer
Web Resource
Details down arrow
7. The role of microtubules in cell biology, neurobiology, and oncology
by Fojo, Antonio Tito, 1952 and SpringerLink (Online service)
2008, Cancer drug discovery and development, ISBN 1597453366
Chemotherapy | drug therapy | Microtubules | methods | Cytological Techniques | Neurobiology | Cytology | physiology | Neoplasms | Nervous System Diseases | Cancer
Web Resource
Details down arrow
8. Precision oncology: A strategy we were not ready to deploy
by Fojo, Tito
Seminars in Oncology, ISSN 0093-7754, 02/2016, Volume 43, Issue 1, pp. 9 - 12
MELANOMA | CANCERS | ONCOLOGY | ABL TYROSINE KINASE | INHIBITOR | CHRONIC MYELOID-LEUKEMIA | VEMURAFENIB | Pharmacogenetics | Evidence-Based Nursing | Neoplasms - genetics | Humans | Neoplasms - drug therapy | Precision Medicine | Randomized Controlled Trials as Topic
Journal Article
Details down arrow
9. Full Text Sunitinib Does Not Accelerate Tumor Growth in Patients with Metastatic Renal Cell Carcinoma
by Blagoev, Krastan B and Wilkerson, Julia and Stein, Wilfred D and Motzer, Robert J and Bates, Susan E and Fojo, A. Tito
Cell Reports, ISSN 2211-1247, 02/2013, Volume 3, Issue 2, pp. 277 - 281
Preclinical studies have suggested that sunitinib accelerates metastases in animals, ascribing this to inhibition of the vascular endothelial growth factor... 
SURVIVAL | INTERFERON-ALPHA | INHIBITOR | CELL BIOLOGY | Cell Proliferation | Humans | Interferon-alpha - therapeutic use | Antineoplastic Agents - therapeutic use | Kidney Neoplasms - mortality | Carcinoma, Renal Cell - mortality | Carcinoma, Renal Cell - secondary | Survival Analysis | Indoles - therapeutic use | Carcinoma, Renal Cell - drug therapy | Kidney Neoplasms - drug therapy | Kidney Neoplasms - secondary | Pyrroles - therapeutic use | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Phase II Multi-Institutional Trial of the Histone Deacetylase Inhibitor Romidepsin As Monotherapy for Patients With Cutaneous T-Cell Lymphoma
by Richard L. Piekarz and Robin Frye and Maria Turner and John J. Wright and Steven L. Allen and Mark H. Kirschbaum and Jasmine Zain and H. Miles Prince and John P. Leonard and Larisa J. Geskin and Craig Reeder and David Joske and William D. Figg and Erin R. Gardner and Seth M. Steinberg and Elaine S. Jaffe and Maryalice Stetler-Stevenson and Stephen Lade and A. Tito Fojo and Susan E. Bates
Journal of Clinical Oncology, ISSN 0732-183X, 11/2009, Volume 27, Issue 32, pp. 5410 - 5417
Purpose Romidepsin (depsipeptide or FK228) is a member of a new class of antineoplastic agents active in T-cell lymphoma, the histone deacetylase inhibitors.... 
POPULATION | ONCOLOGY | CLINICAL-TRIALS | MYCOSIS-FUNGOIDES | DIFFERENTIATION | INDUCERS | SEZARY-SYNDROME | IDENTIFICATION | DEPSIPEPTIDE FR901228 | CANCER-THERAPY | FK228 | Nausea - chemically induced | Area Under Curve | Humans | Middle Aged | Antibiotics, Antineoplastic - adverse effects | Depsipeptides - pharmacokinetics | Male | Metabolic Clearance Rate | Fatigue - chemically induced | Lymphoma, T-Cell, Cutaneous - drug therapy | Histone Deacetylase Inhibitors - pharmacokinetics | Aged, 80 and over | Adult | Female | Depsipeptides - therapeutic use | Antibiotics, Antineoplastic - pharmacokinetics | Depsipeptides - adverse effects | Treatment Outcome | Thrombocytopenia - chemically induced | Lymphoma, T-Cell, Cutaneous - pathology | Antibiotics, Antineoplastic - therapeutic use | Aged | Histone Deacetylase Inhibitors - therapeutic use | Leukemia - chemically induced | Histone Deacetylase Inhibitors - adverse effects | Index Medicus | Original Reports | Hema13
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Delivering affordable cancer care in high-income countries
by Sullivan, Richard, Prof and Peppercorn, Jeffrey, Prof and Sikora, Karol, Prof and Zalcberg, John, Prof and Meropol, Neal J, Prof and Amir, Eitan, MBChB and Khayat, David, MD and Boyle, Peter, Prof and Autier, Philippe, PhD and Tannock, Ian F, Prof and Fojo, Tito, MD and Siderov, Jim, MClinPharm and Williamson, Steve, MRPharmS and Camporesi, Silvia, PhD and McVie, J Gordon, Prof and Purushotham, Arnie D, Prof and Naredi, Peter, Prof and Eggermont, Alexander, Prof and Brennan, Murray F, Prof and Steinberg, Michael L, Prof and De Ridder, Mark, Prof and McCloskey, Susan A, MD and Verellen, Dirk, Prof and Roberts, Terence, MD and Storme, Guy, Prof and Hicks, Rodney J, Prof and Ell, Peter J, Prof and Hirsch, Bradford R, MD and Carbone, David P, Prof and Schulman, Kevin A, Prof and Catchpole, Paul, PhD and Taylor, David, Prof and Geissler, Jan, PhD and Brinker, Nancy G and Meltzer, David, Prof and Kerr, David, Prof and Aapro, Matti, Prof and Medicinska fakulteten and Kirurgi and Institutionen för kirurgisk och perioperativ vetenskap and Umeå universitet
Lancet Oncology, The, ISSN 1470-2045, 2011, Volume 12, Issue 10, pp. 933 - 980
Summary The burden of cancer is growing, and the disease is becoming a major economic expenditure for all developed countries. In 2008, the worldwide cost of... 
Hematology, Oncology and Palliative Medicine | CELL LUNG-CANCER | COST-EFFECTIVENESS ANALYSIS | HEALTH-TECHNOLOGY-ASSESSMENT | ERLOTINIB PLUS GEMCITABINE | STAGE BREAST-CANCER | POSITRON-EMISSION-TOMOGRAPHY | ONCOLOGY | RANDOMIZED PHASE-III | CLINICAL-TRIALS | BODY RADIATION-THERAPY | ADVANCED PANCREATIC-CANCER | Health Expenditures - legislation & jurisprudence | Neoplasms - economics | Delivery of Health Care, Integrated - legislation & jurisprudence | Health Care Costs - legislation & jurisprudence | United States | Europe | Humans | Health Services Accessibility - legislation & jurisprudence | Neoplasms - diagnosis | Models, Economic | Health Care Reform - economics | Health Services Misuse - economics | Health Services Research | Socioeconomic Factors | Cost Savings | Health Services Accessibility - economics | Neoplasms - therapy | Healthcare Disparities - economics | Delivery of Health Care, Integrated - economics | Cost-Benefit Analysis | Australia | Health Policy - economics | Insurance, Health - economics | Drugs | Medical colleges | Care and treatment | Oncology, Experimental | Leukemia | Radiation | Research | Cancer | Index Medicus | Clinical Medicine | Medical and Health Sciences | Cancer and Oncology | Klinisk medicin | Medicin och hälsovetenskap | Cancer och onkologi
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. The high cost of ignorance in oncology
by Fojo, Tito
Seminars in Oncology, ISSN 0093-7754, 12/2016, Volume 43, Issue 6, pp. 623 - 624
ONCOLOGY
Journal Article
Details down arrow
13. Pseudo-progressing to an unmet need
by Fojo, T
SEMINARS IN ONCOLOGY, ISSN 0093-7754, 02/2017, Volume 44, Issue 1, pp. 1 - 2
ONCOLOGY | Neoplasms - therapy | Neoplasms - pathology | Humans | Disease Progression | Needs Assessment
Journal Article
Details down arrow
14. Full Text Clinical trials: New drug for pancreatic cancer highlights the dual effect of regulatory approvals
by Bates, Susan E and Fojo, Tito
Nature Reviews Clinical Oncology, ISSN 1759-4774, 04/2016, Volume 13, Issue 4, pp. 205 - 206
Pancreatic Neoplasms - drug therapy | Carcinoma, Pancreatic Ductal - drug therapy | Female | Male | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Humans
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Full Text Price, value, and the cost of cancer drugs
by Fojo, Tito and Lo, Andrew W
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 1, pp. 3 - 5
Hematology, Oncology and Palliative Medicine | ONCOLOGY | Drug Costs - statistics & numerical data | Drug Industry - economics | Humans | Antineoplastic Agents - economics | Antimitotic agents | Antineoplastic agents | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
16. Moving a pioneer journal into the future
by Fojo, Tito
Seminars in Oncology, ISSN 0093-7754, 02/2016, Volume 43, Issue 1, pp. 1 - 1
ONCOLOGY | Humans | Periodicals as Topic - trends | Neoplasms
Journal Article
Details down arrow
17. Immunotherapy for adrenocortical cancer
by Fojo, AT
SEMINARS IN ONCOLOGY, ISSN 0093-7754, 02/2019, Volume 46, Issue 1, pp. 1 - 2
ONCOLOGY | Neoplastic Syndromes, Hereditary - drug therapy | Antibodies, Monoclonal, Humanized - therapeutic use | Neoplastic Syndromes, Hereditary - immunology | Colorectal Neoplasms - genetics | Humans | Brain Neoplasms - genetics | Brain Neoplasms - drug therapy | Adrenal Cortex Neoplasms - drug therapy | Adrenal Cortex Neoplasms - genetics | Adrenal Cortex Neoplasms - immunology | Brain Neoplasms - immunology | Colorectal Neoplasms - immunology | Colorectal Neoplasms - drug therapy | Immunotherapy | Neoplastic Syndromes, Hereditary - genetics
Journal Article
Details down arrow
18. Full Text Unintended Consequences of Expensive Cancer Therapeutics—The Pursuit of Marginal Indications and a Me-Too Mentality That Stifles Innovation and Creativity: The John Conley Lecture
by Fojo, Tito and Mailankody, Sham and Lo, Andrew
JAMA Otolaryngology–Head & Neck Surgery, ISSN 2168-6181, 12/2014, Volume 140, Issue 12, pp. 1225 - 1236
Cancer is expected to continue as a major health and economic problem worldwide. Several factors are contributing to the increasing economic burden imposed by... 
PHASE-III TRIAL | BREAST-CANCER | SURGERY | LUNG-CANCER | IXABEPILONE PLUS CAPECITABINE | OTORHINOLARYNGOLOGY | DOUBLE-BLIND | OPEN-LABEL | INCREASED SURVIVAL | GASTROINTESTINAL STROMAL TUMORS | RENAL-CELL CARCINOMA | METASTATIC COLORECTAL-CANCER | Medical Oncology | Health Care Costs | United States | Humans | Head and Neck Neoplasms - therapy | Diffusion of Innovation | Therapies, Investigational | Unnecessary Procedures | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
19. Full Text Somatic HIF2A Gain-of-Function Mutations in Paraganglioma with Polycythemia
by Zhuang, Zhengping and Yang, Chunzhang and Lorenzo, Felipe and Merino, Maria and Fojo, Tito and Kebebew, Electron and Popovic, Vera and Stratakis, Constantine A and Prchal, Josef T and Pacak, Karel
The New England Journal of Medicine, ISSN 0028-4793, 09/2012, Volume 367, Issue 10, pp. 922 - 930
Two patients with paraganglioma (one of whom also had somatostatinoma) were found to have mutations in HIF2A that altered HIF-2α turnover and led to excess... 
MEDICINE, GENERAL & INTERNAL | HIF-2-ALPHA | INHIBITION | PHEOCHROMOCYTOMA | GENE | HIF-1-ALPHA | CANCER | ERYTHROCYTOSIS | TUMORIGENESIS | HYPOXIA-INDUCIBLE FACTORS | Up-Regulation | Basic Helix-Loop-Helix Transcription Factors - genetics | Hydroxylation | Paraganglioma - genetics | Humans | Abdominal Neoplasms - complications | Pancreatic Neoplasms - genetics | Paraganglioma - complications | Somatostatinoma - complications | Paraganglioma - blood | Somatostatinoma - genetics | Basic Helix-Loop-Helix Transcription Factors - metabolism | Polycythemia - etiology | DNA Mutational Analysis | Abdominal Neoplasms - genetics | Adolescent | Adrenal Gland Neoplasms - complications | Adult | Female | Transcription, Genetic | Mutation | Adrenal Gland Neoplasms - genetics | Causes of | Genetic aspects | Research | Gene mutations | Polycythemia | Risk factors | Hypoxia-inducible factors | Erythropoiesis | Energy metabolism | Transcription factors | Nuclear magnetic resonance--NMR | Genes | Childrens health | Paraganglioma | Metastasis | Patients | Abdomen | Proteins | Mutagenesis | Plasmids | Hypoxia | Tumorigenesis | Age | Deoxyribonucleic acid--DNA | Tumors | Cancer | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
20. Cuba Sí. Cancer No
by Fojo, Antonio Tito
Seminars in Oncology, ISSN 0093-7754, 01/2018, Volume 45, Issue 1-2, pp. 11 - 11
ONCOLOGY
Journal Article
Details down arrow
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.